Literature DB >> 32912387

Post-tuberculosis lung health: perspectives from the First International Symposium.

B W Allwood1, M M van der Zalm2, A F S Amaral3, A Byrne4, S Datta5, U Egere6, C A Evans5, D Evans7, D M Gray8, G Hoddinott2, O Ivanova9, R Jones10, G Makanda11, F M Marx12, J Meghji13, S Mpagama14, J G Pasipanodya15, A Rachow16, I Schoeman11, J Shaw1, C Stek17, S van Kampen18, D von Delft11, N F Walker19, R S Wallis20, K Mortimer21.   

Abstract

ALTHOUGH CURABLE, TB frequently leaves the individual with chronic physical and psycho-social impairment, but these consequences have been largely neglected. The 1st International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to discuss priorities and gaps in addressing this issue. A barrier to progress has been the varied terminology and nomenclature, so the Delphi process was used to achieve consensus on definitions. Lack of sufficient evidence hampered definitive recommendations in most domains, including prevention and treatment of post-TB lung disease (PTLD), but the discussions clarified the research needed. A consensus was reached on a toolkit for future PTLD measurement and on PTLD patterns to be considered. The importance of extra-pulmonary consequences and progressive impairment throughout the life-course was identified, including TB recurrence and increased mortality. Patient advocates emphasised the need to address the psychological and social impacts post TB and called for clinical guidance. More generally, there is an urgent need for increased awareness and research into post-TB complications.

Entities:  

Mesh:

Year:  2020        PMID: 32912387     DOI: 10.5588/ijtld.20.0067

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  23 in total

1.  The burden and determinants of post-TB lung disease.

Authors:  S G Mpagama; K S Msaji; O Kaswaga; L J Zurba; P M Mbelele; B W Allwood; B-S Ngungwa; R M Kisonga; M Lesosky; J Rylance; K Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 2.373

Review 2.  Host-directed immunotherapy of viral and bacterial infections: past, present and future.

Authors:  Robert S Wallis; Anne O'Garra; Alan Sher; Andreas Wack
Journal:  Nat Rev Immunol       Date:  2022-06-07       Impact factor: 108.555

3.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

4.  Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment.

Authors:  Caleb Nwongbouwoh Muefong; Olumuyiwa Owolabi; Simon Donkor; Salome Charalambous; Abhishek Bakuli; Andrea Rachow; Christof Geldmacher; Jayne S Sutherland
Journal:  Clin Infect Dis       Date:  2022-05-30       Impact factor: 20.999

5.  Post-tuberculosis airway disease: A population-based cohort study of people immigrating to British Columbia, Canada, 1985-2015.

Authors:  C Andrew Basham; Mohammad E Karim; Victoria J Cook; David M Patrick; James C Johnston
Journal:  EClinicalMedicine       Date:  2021-02-26

6.  Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.

Authors:  B W Allwood; M Stolbrink; N Baines; E Louw; D T Wademan; A Lupton-Smith; S Nel; D Maree; S Mpagama; M Osman; F M Marx; G Hoddinott; M Lesosky; J Rylance; K Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2021-04-01       Impact factor: 2.373

7.  Impact of post-tuberculosis lung disease on health-related quality of life in patients from two tertiary hospitals in Lagos, Nigeria.

Authors:  O B Ozoh; O O Ojo; M G Dania; S K Dede; O A Adegboyega; N K Irurhe; M Olowoyeye; O O Adeyeye
Journal:  Afr J Thorac Crit Care Med       Date:  2021-06-23

8.  Clinical and radiographic characteristics of presumptive tuberculosis patients previously treated for tuberculosis in Zambia.

Authors:  Kondwelani Mateyo; Andrew D Kerkhoff; Ian Dunn; Mutinta S Nteeni; Monde Muyoyeta
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

Review 9.  HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies.

Authors:  Alexander W Kay; Helena Rabie; Elizabeth Maleche-Obimbo; Moorine Penninah Sekadde; Mark F Cotton; Anna M Mandalakas
Journal:  Pathogens       Date:  2021-12-29

Review 10.  The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults.

Authors:  Patricia Moscibrodzki; Leslie A Enane; Graeme Hoddinott; Meredith B Brooks; Virginia Byron; Jennifer Furin; James A Seddon; Lily Meyersohn; Silvia S Chiang
Journal:  Pathogens       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.